Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625391 · ClinicalTrials.gov registry record · Phase 1
Green Tea and Tai Chi for Bone Health
A Phase 1 study, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 171
- Enrollment target
NCT00625391 is a Phase 1 study that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 171 participants.
The verdict
NCT00625391, a Phase 1 study, has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 171 participants
- Enrollment target
Study Summary
Osteoporosis is a major health problem in postmenopausal women. Our long-term goal is to develop a new alternative treatment that include a dietary supplement (green tea extract) and a mind-body exercise (Tai Chi) for lessening bone loss in postmenopausal women with low bone mass. A combination of dietary supplement and moderate intensity exercise now becomes a new alternative treatment in reducing bone loss in postmenopausal women with low bone mass, due to the possible stronger effects of the combination than individual treatments. Objective: To test a CAM intervention including green tea polyphenol (GTP) and Tai Chi (TC) exercise for feasibility, and to quantitatively assess their individual and conjugate effects on postmenopausal women with osteopenia. Hypotheses: (1) 24 weeks of GTP supplement, TC exercise, and their combination will benefit bone remodeling as measured by bone biomarkers and muscle strength/physical function in postmenopausal women with osteopenia compared to those receiving placebo only, and (2) the changes in bone biomarkers associated with bone remodeling will be correlated with the changes in oxidative stress.
Interventions
- DRUG Placebo
- DRUG Green Tea Polyphenols (GTP)
- DRUG Placebo+Tai Chi (TC)
- DRUG GTP+TC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00625391
The ClinicalTrials.gov registry entry for NCT00625391 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00625391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00625391 about?
NCT00625391 is a clinical study titled "Green Tea and Tai Chi for Bone Health". Osteoporosis is a major health problem in postmenopausal women. Our long-term goal is to develop a new alternative treatment that include a dietary supplement (green tea extract) and a mind-body exercise (Tai Chi) for lessening bone loss in postmenopausal women with low bone mass. A combination of d...
What is the current status of trial NCT00625391?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 171 participants. The study started on 2008-02. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00625391?
The interventions under investigation include: Placebo (DRUG), Green Tea Polyphenols (GTP) (DRUG), Placebo+Tai Chi (TC) (DRUG), GTP+TC (DRUG).
Who is sponsoring clinical trial NCT00625391?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.